John Paulson Paulson & Co
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$290M |
| 2 |
BID
Sotheby's
BID
|
+$141M |
| 3 |
AGN
Allergan plc
AGN
|
+$96.9M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
+$92M |
| 5 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$82.7M |
| 2 |
TVPT
Travelport Worldwide Limited
TVPT
|
+$51.9M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$42.4M |
| 4 |
AABA
Altaba Inc
AABA
|
+$33.8M |
| 5 |
Fox Class B
FOX
|
+$24.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.93% |
| 2 | Communication Services | 14.92% |
| 3 | Materials | 9.86% |
| 4 | Energy | 6% |
| 5 | Technology | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR Gold Trust
GLD
$152B
| $575M | 9.78% |
4,320,022
| – | – |
|
2
Bausch Health
BHC
$2.41B
| $526M | 8.93% |
20,839,035
| – | – |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $377M | 6.4% |
2,249,500
+700,000
| +45% | +$96.9M |
|
|
DISCK
4
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $311M | 5.28% |
10,922,500
| – | – |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $310M | 5.26% |
3,350,000
+50,000
| +2% | +$4.75M |
|
|
APC
6
DELISTED
Anadarko Petroleum
APC
| $305M | 5.18% |
+4,320,000
| New | +$290M |
|
7
Takeda Pharmaceutical
TAK
$58.1B
| $234M | 3.98% |
13,244,711
| – | – |
|
|
AAMI
8
Acadian Asset Management
AAMI
$3.28B
| $228M | 3.88% |
20,000,552
| – | – |
|
9
AngloGold Ashanti
AU
$61.3B
| $228M | 3.87% |
12,782,400
| – | – |
|
10
Viatris
VTRS
$18.7B
| $210M | 3.56% |
11,005,400
| – | – |
|
|
BID
11
DELISTED
Sotheby's
BID
| $196M | 3.33% |
+3,367,800
| New | +$141M |
|
|
DISH
12
DELISTED
DISH Network Corp.
DISH
| $191M | 3.25% |
4,973,500
| – | – |
|
|
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
| $168M | 2.85% |
587,700
+272,800
| +87% | +$75.2M |
|
14
PUT
VanEck Gold Miners ETF
GDX
$31.8B
| $166M | 2.82% |
6,500,000
+6,200,000
| +2,067% | +$137M |
|
15
Lyft
LYFT
$6.61B
| $163M | 2.77% |
2,477,570
| – | – |
|
|
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $160M | 2.73% |
6,670,700
| – | – |
|
|
ARRY
17
DELISTED
Array Biopharma Inc
ARRY
| $152M | 2.58% |
+3,275,700
| New | +$92M |
|
18
T-Mobile US
TMUS
$196B
| $145M | 2.46% |
1,955,600
| – | – |
|
|
AABA
19
DELISTED
Altaba Inc
AABA
| $132M | 2.24% |
1,900,163
-482,400
| -20% | -$33.8M |
|
20
NovaGold Resources
NG
$3.83B
| $130M | 2.21% |
21,992,896
| – | – |
|
21
PUT
Tesla
TSLA
$1.43T
| $120M | 2.04% |
+8,047,500
| New | +$125M |
|
|
ONCE
22
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $77.6M | 1.32% |
+757,807
| New | +$81.8M |
|
23
TIM SA
TIMB
$8.52B
| $74.8M | 1.27% |
5,000,000
| – | – |
|
24
PG&E
PCG
$38.8B
| $68.8M | 1.17% |
+3,000,810
| New | +$60.3M |
|
|
S
25
DELISTED
Sprint Corporation
S
| $52.6M | 0.89% |
8,000,000
+4,885,100
| +157% | +$30.9M |
|
Similar funds
John Paulson's Q2 2019 Portfolio in Review
As of Q2 2019, John Paulson held 64 positions worth $5.88B, up 23% from $4.76B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
John Paulson deployed $891M of net new capital in Q2 2019, opening 10 new positions and adding to 8 existing holdings. Its largest new stake was Anadarko Petroleum: 4,320,000 shares worth $305M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 43% a quarter earlier, followed by Communication Services and Materials.
On the sell side, the largest reduction was Red Hat Inc, an estimated $42.4M trimmed.
- John Paulson's largest Q2 2019 buy was Anadarko Petroleum: 4,320,000 shares worth $305M.
- John Paulson added most to Allergan plc in Q2 2019, an estimated $96.9M increase.
- John Paulson's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $42.4M.
- John Paulson fully exited Centene in Q2 2019, selling an estimated $82.7M.
- John Paulson's ten largest holdings make up 56% of its $5.88B portfolio in Q2 2019.
- John Paulson opened 10 new positions and closed 13 in Q2 2019.
- John Paulson's portfolio value rose 23% quarter-over-quarter to $5.88B.
Based on Paulson & Co's 13F filing for Q2 2019, filed 14 Aug 2019.